Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Consolidation Therapy With Brentuximab Vedotin After Allogeneic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03652441
Recruitment Status : Not yet recruiting
First Posted : August 29, 2018
Last Update Posted : September 5, 2018
Sponsor:
Information provided by (Responsible Party):
Christoph Scheid, University of Cologne

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Not yet recruiting
  Estimated Primary Completion Date : December 2021
  Estimated Study Completion Date : December 2022